VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Vi-TT
Phase 3
Biologic
I
International Vaccine Institute
1
Indications
2
Total Trials
1
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Vaccine Effectiveness
Recruiting
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Vaccine Effectiveness
Phase 3
Recruiting
Clinical
Trials by Indication
[1]
Effectiveness
1 trial
Effectiveness of a Typhoid Conjugate Vaccine in DRC
Unknown status
·
I
International Vaccine Institute
·
Phase 4
·
NCT05119426
·
48,000 enrolled
Vaccine Effectiveness
1 trial
Evaluation of Typhoid Conjugate Vaccine Effectiveness in Ghana
Recruiting
·
I
International Vaccine Institute
·
Phase 4
·
NCT04852185
·
23,000 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
2 trial records for Vi-TT. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Vi-TT compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Vi-TT. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
International Vaccine Institute company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Biologic
[2]
Highest Phase
Phase 3
[1]
Company
I
International Vaccine Institute
Related News